178 related articles for article (PubMed ID: 14632763)
1. Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features.
Takagi K; Kawaguchi Y; Hara M; Sugiura T; Harigai M; Kamatani N
Clin Exp Immunol; 2003 Dec; 134(3):538-44. PubMed ID: 14632763
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis.
Yamamoto T; Katayama I; Nishioka K
J Rheumatol; 1998 Feb; 25(2):314-7. PubMed ID: 9489825
[TBL] [Abstract][Full Text] [Related]
3. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.
Dooley A; Gao B; Bradley N; Abraham DJ; Black CM; Jacobs M; Bruckdorfer KR
Rheumatology (Oxford); 2006 Jun; 45(6):676-84. PubMed ID: 16399843
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma.
Romero LI; Zhang DN; Cooke JP; Ho HK; Avalos E; Herrera R; Herron GS
Vasc Med; 2000; 5(3):147-58. PubMed ID: 11104297
[TBL] [Abstract][Full Text] [Related]
6. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
[TBL] [Abstract][Full Text] [Related]
7. Increased alveolar concentration of nitric oxide is related to serum-induced lung fibroblast proliferation in patients with systemic sclerosis.
Hua-Huy T; Tiev KP; Chéreau C; Duong-Quy S; Cabane J; Dinh-Xuan AT
J Rheumatol; 2010 Aug; 37(8):1680-7. PubMed ID: 20595271
[TBL] [Abstract][Full Text] [Related]
8. Variations of neuronal nitric oxide synthase in systemic sclerosis skin.
Ibba-Manneschi L; Niissalo S; Milia AF; Allanore Y; Del Rosso A; Pacini A; Manetti M; Toscano A; Cipriani P; Liakouli V; Giacomelli R; Kahan A; Konttinen YT; Matucci-Cerinic M
Arthritis Rheum; 2006 Jan; 54(1):202-13. PubMed ID: 16385516
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase expression and activity in the tight-skin mouse model of fibrosis.
Dooley A; Low SY; Holmes A; Kidane AG; Abraham DJ; Black CM; Bruckdorfer KR
Rheumatology (Oxford); 2008 Mar; 47(3):272-80. PubMed ID: 18238792
[TBL] [Abstract][Full Text] [Related]
10. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
11. Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis.
Ichimura Y; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Toyama T; Tada Y; Sugaya M; Sato S; Kadono T
Arthritis Rheumatol; 2015 Dec; 67(12):3245-55. PubMed ID: 26245842
[TBL] [Abstract][Full Text] [Related]
12. Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis.
Kowal-Bielecka O; Distler O; Neidhart M; Künzler P; Rethage J; Nawrath M; Carossino A; Pap T; Müller-Ladner U; Michel BA; Sierakowski S; Matucci-Cerinic M; Gay RE; Gay S
Arthritis Rheum; 2001 Aug; 44(8):1865-75. PubMed ID: 11508440
[TBL] [Abstract][Full Text] [Related]
13. Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.
Kawaguchi Y; Suzuki K; Hara M; Hidaka T; Ishizuka T; Kawagoe M; Nakamura H
Ann Rheum Dis; 1994 Aug; 53(8):506-10. PubMed ID: 7944634
[TBL] [Abstract][Full Text] [Related]
14. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
[TBL] [Abstract][Full Text] [Related]
15. NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity.
Kawaguchi Y; Tochimoto A; Hara M; Kawamoto M; Sugiura T; Katsumata Y; Okada J; Kondo H; Okubo M; Kamatani N
Arthritis Res Ther; 2006; 8(4):R104. PubMed ID: 16813666
[TBL] [Abstract][Full Text] [Related]
16. A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response.
Masui Y; Asano Y; Shibata S; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
Rheumatology (Oxford); 2013 Jul; 52(7):1239-44. PubMed ID: 23443327
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Sato S; Nagaoka T; Hasegawa M; Tamatani T; Nakanishi T; Takigawa M; Takehara K
J Rheumatol; 2000 Jan; 27(1):149-54. PubMed ID: 10648031
[TBL] [Abstract][Full Text] [Related]
18. A reactive oxygen species-mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis.
Spadoni T; Svegliati Baroni S; Amico D; Albani L; Moroncini G; Avvedimento EV; Gabrielli A
Arthritis Rheumatol; 2015 Jun; 67(6):1611-22. PubMed ID: 25707572
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
[TBL] [Abstract][Full Text] [Related]
20. Protease nexin-1 messenger RNA levels are not affected by serum or interferon beta in cultured systemic sclerosis fibroblasts.
de Oliveira JG; Guedes AC; Lanna CC; Coelho LF; Prados RZ; Feghali C; Ferreira PC; Kroon EG
Arch Dermatol Res; 2002 Jan; 293(11):584-9. PubMed ID: 11876527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
